Pharmaceutical Packaging Systems – Page 6

Primary Packaging Material Selection SOP: Key Elements and Practical Examples

Identifying symptoms signaling issues with primary packaging materials involves monitoring various factors during the manufacturing process. Several key symptoms may indicate a need for a reevaluation of packaging material selection:Click…

Container Closure Integrity Testing: How to Build a Risk-Based CCI Strategy

Identifying symptoms of failure in container closure integrity can be challenging but is crucial for timely intervention. Common signals that indicate potential CCI failures include:Click to read the full article.

Vacuum Decay vs HVLD: Choosing the Right CCI Method for Sterile Products

Recognizing the symptoms of potential CCI failures is crucial for timely intervention. The following signals can indicate integrity issues in sterile packaging:Click to read the full article.

How to Investigate Container Closure Integrity Failures in Vials

Identifying the symptoms of a container closure integrity failure is the first step in addressing the issue. Common signals include:Click to read the full article.

CCI Testing for Lyophilized Products: Critical Risks and Controls

In this case study, the manufacturing team began noticing abnormal signals during the final quality checks of lyophilized products. The symptoms included:Click to read the full article.

Microbial Ingress vs Deterministic Leak Testing: What Pharma Teams Must Know

Recognizing early warning signals related to container closure integrity is essential to address issues before they escalate. Common symptoms that may indicate problems pertaining to microbial ingress and leak testing…

How to Validate Vacuum Decay Testing for Pharmaceutical Containers

Identifying the signals that indicate potential failures in vacuum decay testing is key to preventing compromised product integrity. Common symptoms include:Click to read the full article.

HVLD Testing for Liquid-Filled Containers: Benefits, Limits, and Failure Modes

Detection of anomalous conditions in pharmaceutical packaging can be an early indication of impending failures. Here are common symptoms that may signal issues:Click to read the full article.

Helium Leak Testing in CCI Development: When and How to Use It

In any pharmaceutical manufacturing context, recognizing the symptoms related to CCI failure is the first step to mitigating risk. Typical signals that indicate a potential leak include:Click to read the…

Container Closure Integrity for Prefilled Syringes: Plunger, Tip Cap, and Needle Shield Risks

During routine quality control checks at a pharmaceutical manufacturing facility, operators observed an increased frequency of deviations concerning the sterility of prefilled syringes. Some specific symptoms included:Click to read the…

How Crimping Parameters Affect CCI in Sterile Vials

Before addressing crimping parameters, it’s essential to recognize the symptoms indicating a potential CCI failure. Common signs include:Click to read the full article.

CCI Failure During Shipping: Root Causes and CAPA Strategy

The detection of container closure integrity failures can manifest in various forms during shipping or in the laboratory. Symptoms may include:Click to read the full article.